Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Crescent Biopharma (CBIO) Interest Expenses (2025)

Crescent Biopharma (CBIO) has disclosed Interest Expenses for 1 consecutive years, with $1.1 million as the latest value for Q2 2025.

  • Quarterly Interest Expenses changed N/A to $1.1 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2025, changed N/A year-over-year, with the annual reading at $2.2 million for FY2025, N/A changed from the prior year.
  • Interest Expenses for Q2 2025 was $1.1 million at Crescent Biopharma.
  • The five-year high for Interest Expenses was $1.1 million in Q2 2025, with the low at $1.1 million in Q2 2025.